Sun Pharma Q2 profit falls 36% as litigation costs hit earnings
Economic Times
Sun Pharma reported a 36% decline in Q2FY27 net profit to Rs 1,989 crore due to exceptional litigation and acquisition-related costs. Revenue grew 11.8%, supported by strong domestic and emerging market sales, while US formulations weakened.
Summary from Economic Times
Read the full story on Economic TimesTimeline
- Economic Times first reported it
- NDTV Profit reported it
- The Hindu reported it
- Mint reported it
- Latest update
Follow
